Regulation & governance

MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.

A Boot-Camp Flu Outbreak Put Pentagon Vaccine Policy to the Test.

Resistant hypertension may need a diagnostic revolution, not just another drug

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

A Licensing Deal Is Not Access. But It Decides Whether Access Is Possible.

Harlem’s Legionnaires’ Outbreak Was Not Just in the Air. It Was in the System.

Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
